AstraZenecas glorreiche 7
Ein in blogs veröffentlichtes Zitat eines regionalen Verkaufsmanagers in einem internen Newsletter hat AstraZeneca in Schwierigkeiten gebracht. Mit einem schnellen Rauswurf sollte es als Fehlleistung eines Einzelnen
verkauft werden.So einfach ist das in der blogosphere nicht, wie AstraZeneca nun auch schmerzlich spüren muss. Beim Oberwhistleblower Peter Rost hat sich eine Gruppe von sieben AstraZeneca Mitarbeitern gemeldet, die von unethischem Verhalten und die Missachtung von Gesetzen berichten.
From: REDACTED
To: rostpeter@hotmail.com
Subject: AstraZeneca's "Group of Seven"
Date: Thu, 12 Apr 2007 10:09:23
We are a group of 7 honest AstraZeneca employees scattered around headquarters and field sales.
Our goal is for AstraZeneca to once again become an ethical pharmaceutical company.
We have been reporting unethical behavior to the Code of Conduct hotline (888 244-1769) for years. However, the company continues to violate policies developed under the HHS OIG Corporate Integrity Agreement. We are afraid that AZ is not properly notifying OIG of these reports, and have begun to copy OIG (800-447-8477)on everything we submit.
For the most part, the policy violations that we see come from management, and resistance from underlings is met with swift retaliation. Anonymity is essential.
Our main concern with the Mid-Atlantic Oncology Newsletter was actually its directive to misbrand anastrozole by "selling against letrozole" without approved material, head to head studies or data in our prescribing information. The RSD's statements were crude, but not illegal.
We would like to encourage all workers to stand up and report unethical behavior by managers to the Code of Conduct hotline. One of the first directives in our compliance policy is that you have a "duty to report" illegal activity.
To: rostpeter@hotmail.com
Subject: AstraZeneca's "Group of Seven"
Date: Thu, 12 Apr 2007 10:09:23
We are a group of 7 honest AstraZeneca employees scattered around headquarters and field sales.
Our goal is for AstraZeneca to once again become an ethical pharmaceutical company.
We have been reporting unethical behavior to the Code of Conduct hotline (888 244-1769) for years. However, the company continues to violate policies developed under the HHS OIG Corporate Integrity Agreement. We are afraid that AZ is not properly notifying OIG of these reports, and have begun to copy OIG (800-447-8477)on everything we submit.
For the most part, the policy violations that we see come from management, and resistance from underlings is met with swift retaliation. Anonymity is essential.
Our main concern with the Mid-Atlantic Oncology Newsletter was actually its directive to misbrand anastrozole by "selling against letrozole" without approved material, head to head studies or data in our prescribing information. The RSD's statements were crude, but not illegal.
We would like to encourage all workers to stand up and report unethical behavior by managers to the Code of Conduct hotline. One of the first directives in our compliance policy is that you have a "duty to report" illegal activity.
Das wird sicher auch die Behörden interessieren. AstraZeneca hat ein Problem - und einen Fall für das unternehmensinterne security department, das alle Pharmakonzerne unterhalten.
[AstraZeneca - Bucket of cash]
| Autor: strappato 2007-04-13 Link (2 Kommentare) Ihr Kommentar |
hockeystick 2007-04-14
Passend zu dieser Debatte: Die Konsensfindung in St. Gallen.
Die interne AstraZeneca-Präsentation, die Peter Rost inzwischen ins Netz gestellt hat, bestätigt meine Vermutung. Die Zahlen sind etwas anders als in der Darstellung von Nabholtz, weil inzwischen neuere Auswertungen der Studien vorliegen. Es bleibt ein dubioser Quervergleich zwischen zwei Studien mit verschiedenen Patientenpopulationen.
>> Kommentieren
